Intended for UK patients and members of the public
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at yellowcard.mhra.gov.uk. By reporting side effects, you can help provide more information on the safety of this medicine.
Report a side effect or a product complaintProduct Documentation
Last updated on this site: 09 Apr 2025
IB, C.I.2.a - to update SmPC sections 4.4, 4.6, 4.7, 4.8, 5.2, 5.3 and leaflet sections 2 and 3 in-line information with the reference product (FOSAMAX Once Weekly 70 mg tablets; Procedure number: AT/H/0870/001; MAH: Organon Austria GmbH).
Additionally, applicant has updated SmPC section 4.9 and 5.2 with some editorial changes related to typographical error in-line with reference product information.
Last updated on this site: 09 Apr 2025
IB, C.I.2.a - to update SmPC sections 4.4, 4.6, 4.7, 4.8, 5.2, 5.3 and leaflet sections 2 and 3 in-line information with the reference product (FOSAMAX Once Weekly 70 mg tablets; Procedure number: AT/H/0870/001; MAH: Organon Austria GmbH).
Additionally, applicant has updated SmPC section 4.9 and 5.2 with some editorial changes related to typographical error in-line with reference product information.
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at yellowcard.mhra.gov.uk. By reporting side effects, you can help provide more information on the safety of this medicine.
Report a side effect or a product complaintFor any further assistance, please get in touch.